221 related articles for article (PubMed ID: 27522992)
1. Plasma Levels of Presepsin (Soluble CD14-subtype) as a Novel Prognostic Marker for Hemophagocytic Syndrome in Hematological Malignancies.
Nanno S; Koh H; Katayama T; Hashiba M; Sato A; Makuuchi Y; Nagasaki J; Kuno M; Yoshimura T; Okamura H; Nishimoto M; Hirose A; Nakamae M; Nakane T; Hino M; Nakamae H
Intern Med; 2016; 55(16):2173-84. PubMed ID: 27522992
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic usefulness of plasma presepsin (soluble CD14-subtype) for diagnosing hemophagocytic syndrome in hematological malignancies.
Koh H; Nanno S; Katayama T; Hirose A; Nakamae M; Hino M; Nakamae H
Leuk Lymphoma; 2017 Oct; 58(10):2489-2492. PubMed ID: 28278703
[No Abstract] [Full Text] [Related]
3. Clinical utility of soluble interleukin-2 receptor in hemophagocytic syndromes: a systematic scoping review.
Lin M; Park S; Hayden A; Giustini D; Trinkaus M; Pudek M; Mattman A; Schneider M; Chen LYC
Ann Hematol; 2017 Aug; 96(8):1241-1251. PubMed ID: 28497365
[TBL] [Abstract][Full Text] [Related]
4. Presepsin (Soluble CD14 Subtype): Reference Ranges of a New Sepsis Marker in Term and Preterm Neonates.
Pugni L; Pietrasanta C; Milani S; Vener C; Ronchi A; Falbo M; Arghittu M; Mosca F
PLoS One; 2015; 10(12):e0146020. PubMed ID: 26720209
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for survival of herpes simplex virus-associated hemophagocytic lymphohistiocytosis.
Sonoda M; Ishimura M; Eguchi K; Shiraishi A; Kanno S; Kaku N; Inoue H; Motomura Y; Ochiai M; Sakai Y; Nakayama M; Ohara O; Ohga S
Int J Hematol; 2020 Jan; 111(1):131-136. PubMed ID: 31549293
[TBL] [Abstract][Full Text] [Related]
6. Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial.
Masson S; Caironi P; Spanuth E; Thomae R; Panigada M; Sangiorgi G; Fumagalli R; Mauri T; Isgrò S; Fanizza C; Romero M; Tognoni G; Latini R; Gattinoni L;
Crit Care; 2014 Jan; 18(1):R6. PubMed ID: 24393424
[TBL] [Abstract][Full Text] [Related]
7. Possible prediction of underlying lymphoma by high sIL-2R/ferritin ratio in hemophagocytic syndrome.
Tabata C; Tabata R
Ann Hematol; 2012 Jan; 91(1):63-71. PubMed ID: 21523380
[TBL] [Abstract][Full Text] [Related]
8. Phagocytosis by human monocytes is required for the secretion of presepsin.
Arai Y; Mizugishi K; Nonomura K; Naitoh K; Takaori-Kondo A; Yamashita K
J Infect Chemother; 2015 Aug; 21(8):564-9. PubMed ID: 26026662
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of presepsin for outcomes and complications in enterocutaneous fistula complicated by abdominal sepsis.
Song X; Song Y; Yuan Y; Zhang P; Zhang X
Int J Surg; 2016 Sep; 33 Pt A():96-101. PubMed ID: 27494999
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of presepsin (sCD14 subtype) measurements as a new marker for the diagnosis and prediction of disease severity of sepsis in the Korean population.
Kweon OJ; Choi JH; Park SK; Park AJ
J Crit Care; 2014 Dec; 29(6):965-70. PubMed ID: 25042676
[TBL] [Abstract][Full Text] [Related]
11. A high sIL-2R/ferritin ratio is a useful marker for the diagnosis of lymphoma-associated hemophagocytic syndrome.
Tsuji T; Hirano T; Yamasaki H; Tsuji M; Tsuda H
Ann Hematol; 2014 May; 93(5):821-6. PubMed ID: 24705932
[TBL] [Abstract][Full Text] [Related]
12. [Serum levels of tumor necrosis factor α and interferon γ in patients with hemophagocytic syndrome and its clinical significance].
Wu DX; Wang Z; Lin RR; Wang XL; Wang YN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1505-8. PubMed ID: 22169313
[TBL] [Abstract][Full Text] [Related]
13. Soluble CD14 Subtype-A New Biomarker in Predicting the Outcome of Critically Ill Septic Patients.
Matera G; Quirino A; Peronace C; Settembre P; Marano V; Loria MT; Marascio N; Galati L; Barreca GS; Giancotti A; Amantea B; Liberto MC; Focà A
Am J Med Sci; 2017 Jun; 353(6):543-551. PubMed ID: 28641717
[TBL] [Abstract][Full Text] [Related]
14. Presepsin as a diagnostic marker of bacterial infections in febrile neutropenic pediatric patients with hematological malignancies.
Baraka A; Zakaria M
Int J Hematol; 2018 Aug; 108(2):184-191. PubMed ID: 29616457
[TBL] [Abstract][Full Text] [Related]
15. Plasma presepsin level is an early diagnostic marker of severe febrile neutropenia in hematologic malignancy patients.
Koizumi Y; Shimizu K; Shigeta M; Okuno T; Minamiguchi H; Kito K; Hodohara K; Yamagishi Y; Andoh A; Fujiyama Y; Mikamo H
BMC Infect Dis; 2017 Jan; 17(1):27. PubMed ID: 28056845
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal Evaluation of Plasma Concentrations of Presepsin in Patients after Severe Trauma: A Prospective Observational Study.
Koch C; Ruhrmann S; Pöhlmann M; Schneck E; Arneth B; Zajonz T; Sander M; Weigand MA; Uhle F
Surg Infect (Larchmt); 2018 Jul; 19(5):480-487. PubMed ID: 29683405
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of levels of presepsin (soluble CD14-subtype) in febrile neutropenia in patients with hematological disorders.
Koh H; Aimoto M; Katayama T; Hashiba M; Sato A; Kuno M; Makuuchi Y; Takakuwa T; Okamura H; Hirose A; Nakamae M; Hino M; Nakamae H
J Infect Chemother; 2016 Jul; 22(7):466-71. PubMed ID: 27184936
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 Levels Act as a Diagnostic Marker for Infection and a Prognostic Marker in Patients with Organ Dysfunction in Intensive Care Units.
Takahashi W; Nakada TA; Yazaki M; Oda S
Shock; 2016 Sep; 46(3):254-60. PubMed ID: 27172160
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic performance of procalcitonin, presepsin, and C-reactive protein in patients with hematological malignancies.
Ebihara Y; Kobayashi K; Ishida A; Maeda T; Takahashi N; Taji Y; Asou N; Ikebuchi K
J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 28133789
[TBL] [Abstract][Full Text] [Related]
20. Hypercytokinemia in hemophagocytic syndrome.
Fujiwara F; Hibi S; Imashuku S
Am J Pediatr Hematol Oncol; 1993 Feb; 15(1):92-8. PubMed ID: 8447564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
